TrialCell reports. Medicine2021

Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis.

Feng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.